Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
about
MicroRNAs in glioblastoma multiforme pathogenesis and therapeuticsHypoxamiRs and cancer: from biology to targeted therapyMicro-masters of glioblastoma biology and therapy: increasingly recognized roles for microRNAs.Prognostic significance of low DICER expression regulated by miR-130a in cervical cancerTumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways.Multiple functions of hypoxia-regulated miR-210 in cancer.β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells.Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness.Surprisal analysis of Glioblastoma Multiform (GBM) microRNA dynamics unveils tumor specific phenotype.MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.Clinical implications of microRNAs in cancer.MiR-210 expression reverses radioresistance of stem-like cells of oesophageal squamous cell carcinoma.Targeting the SMO oncogene by miR-326 inhibits glioma biological behaviors and stemnessIdentification of microRNAs that regulate TLR2-mediated trophoblast apoptosis and inhibition of IL-6 mRNA.Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemiaPrognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma.Elevated expression of miR-210 predicts poor survival of cancer patients: a systematic review and meta-analysis.Stability indicators in network reconstruction.MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A.Primary analysis and screening of microRNAs in gastric cancer side population cellsMicroRNAs as potential biomarkers in cancer: opportunities and challengesSerum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of gliomaDo circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathologymiR-340 suppresses glioblastoma multiformeHigh miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.Identification of low miR-105 expression as a novel poor prognostic predictor for human glioma.Diverse microRNAs with convergent functions regulate tumorigenesis.Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygen.MiR-422a acts as a tumor suppressor in glioblastoma by targeting PIK3CA.Emerging biomarkers in glioblastomaMiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.Long non-coding RNA EWSAT1 promotes human nasopharyngeal carcinoma cell growth in vitro by targeting miR-326/-330-5p.Prognostic role of microRNA-210 in various carcinomas: a systematic review and meta-analysis.Loss of MYC and E-box3 binding contributes to defective MYC-mediated transcriptional suppression of human MC-let-7a-1~let-7d in glioblastomaMiR-433-3p suppresses cell growth and enhances chemosensitivity by targeting CREB in human gliomaTumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activationMicroRNAs and cell cycle of malignant glioma.Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis.MicroRNA as potential biomarkers in Glioblastoma.
P2860
Q26747273-4705D37A-15B7-49EC-BA0C-BF22E7C5DF5FQ26863298-BE1475B8-2701-4452-B4C7-402EF447F7B8Q30405560-7B7ED3EF-1705-4D8E-A4D9-DDD5E2E90776Q33720262-9D5F4B83-3FB4-44AF-A975-92173BB7924CQ33764768-B023403B-AFEE-4455-93BC-F2A9711876B7Q33765128-8DD24D8F-AE76-458F-ACD9-5C63F9465BDAQ33908911-ADFE52ED-E0B9-4E7B-8BDC-288CA35F92E3Q33911224-FFE8FEDA-4879-489B-88F3-26273813F1AEQ34268806-07A37E89-523B-458F-BBD5-9C32B4053B81Q34409620-633822B7-035E-46D0-B1B6-63453BB8BB17Q34570698-7D42568D-1452-4085-A5CB-AD3ABBC8F746Q34657610-2B173648-5F72-421F-A048-DB723BE6D1F7Q34886908-7EA0E80C-9B6C-41D8-9DFD-390907BD5FFCQ35021710-98827E4C-797E-4C29-9E9D-49B055A15AE4Q35051430-C65646AA-B12B-47CB-8CD5-A9BC3573EFABQ35103188-7688D092-AA70-46B2-B2B0-D35D749B850CQ35106877-D63826DE-2178-4073-8EB0-F25B3CBE6938Q35108162-59B21D2C-36CC-4C82-A42B-010F5B011C56Q35144855-60202EAA-B42A-4C86-B399-36C0ED219B3CQ35221780-FED89DD1-AD96-4337-9D2F-AAF8F7E10D45Q35271157-FF0C4764-1A13-4CCF-AFBB-817A29551662Q35275041-F1500BFE-E6F6-45D3-B75A-8AE1AA416D32Q35543094-CB858DA6-AB87-40CB-826A-1A3D07E5AE0BQ35832337-837E1FDA-9020-4B3C-BB15-A39C41DCB501Q35919049-9DF4A7C9-C20B-4049-8B7A-4006A236DDD4Q36046299-1E6AE334-A3ED-4A8B-9291-9E69D969C375Q36524574-F1965D7E-6D18-4E80-A7B1-B7C49F9B19B0Q36946799-D2DE6C54-F9CF-4AEC-8520-5FE8B860F4D2Q36991225-33B568F5-6D4E-47AF-844B-7B55EDCA4FC4Q37215533-2F414AA6-E467-4C1A-A0BE-E388974A3ED8Q37226521-00913164-FB0A-4D14-8CA3-55F176AFD409Q37492137-02A58755-821F-4DD2-BD83-E07FFF177F3DQ37530948-4230DC0C-E3C5-435E-BAE4-5CB3B976F303Q37586810-BA780A95-0D8B-48AD-99A1-D04883F349BBQ37636621-28AA70B4-EA59-4EB9-9900-5EADA2D21D5EQ37706301-87F9DBF0-3FF8-4AD3-82AF-C9210899D06FQ37708918-E685399A-3936-4F0A-8695-3942493B7046Q38497875-8492E56E-566E-4C02-8EBA-6DC85F7CF05FQ38580491-08FCD8FA-F538-404B-BE91-6F35F1F68B35Q38590626-BED2B503-70EA-4E7B-A4DA-55D639E426AD
P2860
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Interactions of miR-323/miR-32 ...... tcome of glioblastoma patients
@ast
Interactions of miR-323/miR-32 ...... tcome of glioblastoma patients
@en
type
label
Interactions of miR-323/miR-32 ...... tcome of glioblastoma patients
@ast
Interactions of miR-323/miR-32 ...... tcome of glioblastoma patients
@en
prefLabel
Interactions of miR-323/miR-32 ...... tcome of glioblastoma patients
@ast
Interactions of miR-323/miR-32 ...... tcome of glioblastoma patients
@en
P2093
P2860
P356
P1476
Interactions of miR-323/miR-32 ...... tcome of glioblastoma patients
@en
P2093
P2860
P2888
P356
10.1186/1479-5876-11-10
P577
2013-01-09T00:00:00Z
P5875
P6179
1044001189